TAS-116

Delivery:
oral
Indication:
solid tumors
Locations:
US EU

TAS-116 is a highly potent oral HSP90 inhibitor with unique tissue distribution properties. TAS-116 has the potential to demonstrate antitumor activity, while being designed to limit certain adverse events by unique tissue distribution.

Link to clinicaltrials.gov